# Rakshit Drugs Private Ltd, Hyderabad, India – FDA Inspections

Source: https://www.keypedia.com/companies/rakshit-drugs-private-ltd/d2f83e15-79be-4eaa-a131-e3212c25e99d

> Inspection records and compliance data for Rakshit Drugs Private Ltd in Hyderabad. 1 FDA inspection on record, last inspected May 22, 2018.

---

## Details

- Name: Rakshit Drugs Private Ltd
- FEI Number: 3009404354
- Address Line 1: Survey No. 10/B, Gaddapotharam Village, Jinnaram Mandal
- City: Hyderabad
- Country Name: India
- Address: Survey No. 10/B, Gaddapotharam Village, Jinnaram Mandal, Hyderabad, India
- Country: India

## Related Documents

- FDA Inspection 1064444 - Rakshit Drugs Private Ltd - 2018-05-22 — source: FDA, date: May 22, 2018

## Related Companies

- [Shree Hospital & Critical Care Centre](https://www.keypedia.com/companies/shree-hospital-critical-care-centre/084ee6b5-9445-43b8-8aab-8e38670d2685)
- [AIMS Hospital](https://www.keypedia.com/companies/aims-hospital/679752e7-da88-4980-a41c-6995305ab127)
- [Meshram, Chandrashekhar M.D.](https://www.keypedia.com/companies/meshram-chandrashekhar-md/bff6a1c6-f357-4eae-963c-1d403c59fa2b)
- [Emcure Pharmaceuticals Limited](https://www.keypedia.com/companies/emcure-pharmaceuticals-limited/88e493aa-1d7e-45a7-9f5e-b1fc88435387)
- [Aadhar Health Institute](https://www.keypedia.com/companies/aadhar-health-institute/830c4261-1b41-4112-ad5f-bfd45e80fa7a)
- [Alembic Pharmaceuticals Limited](https://www.keypedia.com/companies/alembic-pharmaceuticals-limited/7657935c-b2c4-4257-82c5-7d50df3cb3d7)
- [Jigar A. Parikh, MBBS, MD](https://www.keypedia.com/companies/jigar-a-parikh-mbbs-md/adb2fa1f-3899-4612-82a6-e45f4f9114a9)
- [Ecron AcuNova, Ltd.](https://www.keypedia.com/companies/ecron-acunova-ltd/5cac3557-7f02-4d7c-92f6-0d24bc45923a)
- [Bangalore Cancer Center Pvt., Ltd](https://www.keypedia.com/companies/bangalore-cancer-center-pvt-ltd/9317b699-1c6f-4404-be9e-3b392615ddd3)
- [Omkar Eye Care Center](https://www.keypedia.com/companies/omkar-eye-care-center/d2456732-a4e3-4756-83da-87c1ad989c7c)